Abbott LaboratoriesABT

Health Care · Health Care Equipment & Services · NYSE · United States · abbott.com

Abbott Laboratories is a global diversified healthcare company that develops, manufactures, and sells medical devices, diagnostics, nutritional products, and branded generic pharmaceuticals worldwide. Their portfolio spans cardiovascular and neuromodulation devices, rapid diagnostics, established pharmaceuticals, and nutrition products sold in over 160 countries. Abbott is known for products such as the FreeStyle Libre continuous glucose monitoring system and a broad range of rapid diagnostic tests.

Key ratios

Operating cash flow growth

9.6%TTM

2025 11.8%2024 17.9%2023 -24.2%

EPS growth

-61.2%TTM

2025 -51.3%2024 134.4%2023 -16.6%

FCF / Sales

16.8%TTM

2025 16.7%2024 15.1%2023 12.6%

Net margin

11.7%TTM

2025 14.7%2024 32.0%2023 14.3%

ROA

5.3%TTM

2025 6.6%2024 6.1%2023 6.1%

ROE

10.6%TTM

2025 13.0%2024 30.9%2023 15.1%

Revenue growth

8.1%TTM

2025 5.7%2024 4.6%2023 -8.1%

Recent news

First Canadian Commercial Use of Abbott's Volt Pulsed Field Ablation System Advances Minimally Invasive Atrial Fibrillation Care 2026-09-15 · CNW Abbott Hosts Conference Call for Second-Quarter Earnings 2026-06-25 · Abbott MediaRoom Abbott Declares 410th Consecutive Quarterly Dividend 2026-06-12 · PR Newswire Abbott data show many people with diabetes may not recognize symptoms of diabetic ketoacidosis 2026-06-06 · Abbott MediaRoom

Track ABT in your journal

Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.

Create a free account

Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer